1. 1151PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study. (23rd October 2018) Authors: Pishvaian, M J; Weiss, G J; Falchook, G S; Yee, N; Gil-Martin, M; Shahda, S; Moreno, V; Brana, I; Crittenden, M; Formenti, S; Al-Rajabi, R; Papadopoulos, K P; Stankevich, E; Feng, M; Li, J; Mathias, M; Kroog, G; Lowy, I; Fury, M G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗